|
| Status |
Public on Nov 10, 2006 |
| Title |
Erythroid progenitors stimulated with EPO |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
CD34+ progenitors were isolated from the bone marrow of three healthy volunteers. CD34+CD71+CD45RA- were FACS sorted to enrich for erythroid progenitors. The cells were cultured for four hours with or without EPO in combination with LY294002, and harvested for RNA extraction, amplification and expression analysis.
A compound treatment design type is where the response to administration of a compound or chemical (including biological compounds such as hormones) is assayed.
Compound Based Treatment: EPO
Keywords: compound_treatment_design
|
| |
|
| Overall design |
Computed
|
| |
|
| Contributor(s) |
Sivertsen EA |
| Citation(s) |
16965383 |
| Submission date |
Nov 09, 2006 |
| Last update date |
Mar 17, 2012 |
| Organization |
Stanford Microarray Database (SMD) |
| E-mail(s) |
array@genome.stanford.edu
|
| Phone |
650-498-6012
|
| URL |
http://genome-www5.stanford.edu/
|
| Department |
Stanford University, School of Medicine
|
| Street address |
300 Pasteur Drive
|
| City |
Stanford |
| State/province |
CA |
| ZIP/Postal code |
94305 |
| Country |
USA |
| |
|
| Platforms (1) |
|
| Samples (12)
|
|
| Relations |
| BioProject |
PRJNA100545 |
Less...
More...